Hospital
Southeast Health Center of Stoddard County, LLC
Southeast Health Center of Stoddard County, LLC was paid $8.37M by Medicaid between Jan 2018 and Dec 2024, across 92 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.
33Billing provider infoSOUTHEAST HEALTH CENTER OF STODDARD COUNTY, LLC
DEXTER, MO 63841
DEXTER, MO 63841
33aNPI1801990825assigned 09/11/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.37M
24GClaims187,674
24DCodes billed92
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Missouri
Rank by total paid#30 of 74
Median peer was paid$4.44M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BERRY, KRISTA controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,192 | $1.22M | |
| 2019 | 26,783 | $1.81M | |
| 2020 | 21,594 | $1.18M | |
| 2021 | 21,600 | $390K | |
| 2022 | 34,436 | $1.26M | |
| 2023 | 33,791 | $1.29M | |
| 2024incomplete | 29,278 | $1.22M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 15,832 | 12,101 | $1.57M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 9,163 | 7,084 | $1.22M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.4% | 4,268 | 3,104 | $789K |
| X4011 | State-specific procedure code | 8.1% | 5,377 | 4,525 | $675K |
| 80053 | Comprehensive metabolic panel | 4.6% | 14,370 | 11,607 | $383K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.4% | 17,341 | 13,892 | $367K |
| 81001 | 3.5% | 9,807 | 8,006 | $290K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.3% | 3,916 | 2,998 | $277K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.9% | 5,616 | 4,477 | $242K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.5% | 8,112 | 6,502 | $207K |
| 87400 | 2.2% | 4,384 | 3,829 | $187K | |
| 71045 | Radiologic examination, chest; single view | 1.9% | 3,773 | 3,012 | $159K |
80 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.8% | 2,654 | $152K |
| 87430 | 1.7% | 1,170 | $144K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.7% | 2,484 | $139K |
| 36415 | Collection of venous blood by venipuncture | 1.7% | 14,786 | $139K |
| Y7506 | 1.2% | 771 | $105K | |
| 82550 | 1.2% | 4,513 | $97K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 824 | $76K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,262 | $75K |
| 81025 | <1% | 1,791 | $72K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,271 | $68K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,271 | $67K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,265 | $63K |
| 84484 | <1% | 4,232 | $63K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 502 | $60K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 521 | $51K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,379 | $49K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 448 | $43K |
| 86756 | <1% | 287 | $41K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,835 | $39K |
| 82553 | <1% | 1,440 | $36K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,345 | $36K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,350 | $34K |
| 86141 | <1% | 1,488 | $30K | |
| 83880 | <1% | 1,296 | $29K | |
| 87040 | <1% | 1,096 | $27K | |
| 80306 | <1% | 2,677 | $26K | |
| 83605 | <1% | 1,067 | $22K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 547 | $21K |
| 87634 | <1% | 349 | $14K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,689 | $12K |
| 83690 | <1% | 2,217 | $11K | |
| 80061 | Lipid panel | <1% | 1,088 | $10K |
| 84145 | <1% | 452 | $10K | |
| 85027 | <1% | 619 | $9K | |
| 85610 | <1% | 633 | $8K | |
| 83735 | <1% | 2,790 | $8K | |
| 85730 | <1% | 608 | $8K | |
| 82803 | <1% | 193 | $8K | |
| 80143 | <1% | 891 | $7K | |
| 80179 | <1% | 841 | $7K | |
| 71250 | <1% | 318 | $7K | |
| 85007 | <1% | 641 | $7K | |
| 82375 | <1% | 179 | $7K | |
| 80076 | <1% | 2,264 | $7K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 141 | $6K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 104 | $6K |
| 87077 | <1% | 63 | $4K | |
| 82150 | <1% | 116 | $4K | |
| 84100 | <1% | 2,159 | $4K | |
| 36591 | <1% | 166 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 564 | $4K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 16 | $4K |
| 87581 | <1% | 17 | $3K | |
| 87486 | <1% | 17 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 17 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 156 | $3K |
| 87807 | <1% | 262 | $3K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 16 | $3K |
| 87186 | <1% | 48 | $3K | |
| 86677 | <1% | 13 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 50 | $1K |
| 82607 | <1% | 99 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 34 | $1K |
| 87187 | <1% | 15 | $1K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 41 | $1K |
| 84550 | <1% | 294 | $987.25 | |
| J3490 | Unclassified drugs | <1% | 4,989 | $915.12 |
| 82728 | <1% | 106 | $641.25 | |
| 83655 | <1% | 90 | $588.60 | |
| 83615 | <1% | 32 | $430.43 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 143 | $357.00 |
| 36600 | <1% | 15 | $254.03 | |
| 84439 | <1% | 19 | $103.80 | |
| 83540 | <1% | 14 | $61.29 | |
| 81003 | <1% | 41 | $59.02 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 1,358 | $0.00 |
| 80050 | General health panel | 0% | 32 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 95 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 13 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBERRY, KRISTA (CFO)
| Provider | Location | Paid |
|---|---|---|
| Southeast Hospital | Cape Girardeau, MO | $34.71M |
| Southeast Missouri Hospital Physicians, LLC | Cape Girardeau, MO | $6.55M |
| Southeast Health Center of Stoddard County, LLC | Dexter, MO | $1.55M |
| Southeast Missouri Hospital Physicians LLC | Cape Girardeau, MO | $1.11M |
| Southeast Health Center of Stoddard County LLC | Dexter, MO | $886K |
| Southeast Health Center of Stoddard County, LLC | Poplar Bluff, MO | $813K |
| Southeast Missouri Hospital Physicians LLC | Cape Girardeau, MO | $640K |
| Southeast Health Center of Stoddard County, LLC | Dexter, MO | $556K |
| Southeast Health Center of Stoddard County, LLC | Malden, MO | $296K |
| Southeast Health Center of Stoddard County LLC | Bernie, MO | $128K |
| Southeast Health Center of Stoddard County LLC | Bloomfield, MO | $29K |
| Southeast Health Center of Stoddard County LLC | New Madrid, MO | $4K |
| Southeast Health Center of Stoddard County LLC | Sikeston, MO | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.